GILEAD SCIENCES, INC. (GILD)
Clinical trial NCT06525389 updates: 1. start date: 2026-07-01 → 2026-09-01 2. completion date: 2031-07-01 → 2031-09-01 3. primary completion date: 2030-07-01 → 2030-09-01
Clinical trial NCT06525389 updates: 1. start date: 2026-07-01 → 2026-09-01 2. completion date: 2031-07-01 → 2031-09-01 3. primary completion date: 2030-07-01 → 2030-09-01
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical